Launch of New Therapies Amplifies Competition in the Dry Eye Disease Pipeline Landscape, Pronounces DelveInsight
08 Jul 2021
Los Angeles, USA, July 07, 2021 (GLOBE NEWSWIRE) -- Launch of New Therapies Amplifies Competition in the Dry Eye Disease Pipeline Landscape, Pronounces DelveInsight
The Dry Eye disease pipeline represents a number of promising therapies in clinical development with novel mechanisms of action (MOAs) ranging from Chemokine receptor antagonists, Syk kinase inhibitorsSyk kinase inhibitors, Lipid modulators, Protein tyrosine kinase inhibitors, Dihydroorotate dehydrogenase inhibitors, Melanocortin type 1 receptor agonists, Melanocortin type 5 receptor agonists, and so many others.
DelveInsight’s ‘Dry Eye Disease (DED) Pipeline Insights’ report presents an exhaustive coverage of the available therapies, Dry Eye Disease emerging therapies in different phases of clinical development, key companies working in the Dry Eye Disease pipeline domain, and future potential of the space.
Some of the focal points picked from the Dry Eye Disease Pipeline report:
Request for Sample to know more about the therapies expected to make grab the maximum patient pool @ Dry Eye Disease Emerging Therapies and Forecast
The Dry Eye Disease Pipeline reports offer a holistic scenario of the ongoing clinical trials, partnerships taking place in the domain, recent happenings in space, and growth prospects across the Dry Eye Disease domain.
Dry Eye Disease: Overview
Dry Eye Disease (DED) is a complex, multifactorial condition that causes inflammation of the ocular surface and lacrimal glands and reductions in the quality and/or quantity of tears. It results in visual disturbance, and tear film instability with potential damage to the ocular surface.
Discover more about the disease, treatments, and pipeline therapies @ DED Pipeline Assessment
Dry Eye Disease Pipeline Drugs
Request for Sample to know more @ Dry Eye Disease Pipeline Analysis, Key Companies, and Futuristic Trends
Dry Eye Disease Therapeutics Assessment
The Dry Eye Disease Pipeline report presents a kaleidoscopic view of the DED emerging novel therapies segmented by Stage, Product Type, Route of Administration, Molecule Type, Target, and Mechanism of Action.
By Product Type
By Stage
By Molecule Type
By Route of Administration
By Mechanism of Action
By Targets
For rich insights into merging therapies and assessment, visit Dry Eye Disease Pipeline: Emerging Novel Therapies
Scope of the Dry Eye Disease Pipeline Report
Coverage: GlobalKey Players: Cellix Bio, AbbVie, IACTA Pharmaceuticals, Novaliq, Ocumension Therapeutics, Panoptes Pharma, Palatin Technologies, Aldeyra Therapeutics, among others.Key Dry Eye Disease Pipeline Therapies: CLX-OPH-621, AGN-231868, IC-265, NOV03, OT-202, PP 001, PL 9643, Reproxalap, and others.
Discover more about the scope of the report @ DED Emerging Therapies, Treatments, and Ongoing Clinical Trials
Table of Contents
Learn more about the report offerings @ Dry Eye Disease Pipeline Therapies and Emerging Trends
Audit the market before venturing with DelveInsight’s Due Diligence Services
Related Reports
Dry Eye Disease MarketDelveInsight's "Dry Eye Disease (DED) Market Insights, Epidemiology and Market Forecast-2028" report.
Vernal Keratoconjunctivitis MarketDelveInsight's "Vernal keratoconjunctivitis Market Insights, Epidemiology, and Market Forecast-2030" report.
Adult Myopia MarketDelveInsight’s ‘Adult Myopia Market Insights, Epidemiology, and Market Forecast—2030’ report.
Blepharitis MarketDelveInsight's "Blepharitis Market Insights, Epidemiology, and Market Forecast-2030" report.
Central Retinal Vein Occlusion MarketDelveInsight's "Central Retinal Vein Occlusion Market Insights, Epidemiology, and Market Forecast-2030" report.
Central Serous Chorioretinopathy MarketDelveInsight's "Central Serous Chorioretinopathy Market Insights, Epidemiology, and Market Forecast-2030" report.
Centronuclear Myopathy MarketDelveInsight’s ‘Centronuclear Myopathy Market Insights, Epidemiology, and Market Forecast-2030’ report.
Browse through our related posts
Uveitis Pipeline TherapiesEye Disorders Treatment MarketKeratoconus Therapy Market Allergic Conjunctivitis Therapy Market and Pipeline AnalysisDiabetic Macular Edema Market and dominance of off-label Avastin (Roche/Genentech)
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
For more insights, visit Pharma, Healthcare, and Biotech News
Indications
Drugs
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.